Search Result "anti-IgE directed therapeutics"
Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3 Issue: 3 Year: 2004 Page: 227-229
Author(s): Gennaro DAmato, Gennaro Liccardi, Paolo Noschese, Antonello Salzillo, Maria DAmato, Mario Cazzola
Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
Journal: Current Drug Targets
Volume: 16 Issue: 2 Year: 2015 Page: 171-178
Author(s): Girolamo Pelaia,Alessandro Vatrella,Maria Teresa Busceti,Luca Gallelli,Rosa Terracciano,Rosario Maselli
A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 1 Issue: 3 Year: 2007 Page: 225-231
Author(s): DAmato Gennaro, Piccolo Amedeo, Salzillo Antonello, Noschese Paolo, DAmato Maria, Liccardi Gennaro
Strategies to Develop Allergy Immunotherapeutics with Applications of Directed Molecular Evolution
Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2 Issue: 3 Year: 2003 Page: 228-236
Author(s): Erik Karrer, Steven Bass, Stephen Parmley, Juha Punnonen
The Relevance of IgE in the Pathogenesis of Allergy: The Effect of an Anti-IgE Drug in Asthma and Other Diseases
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 1 Issue: 2 Year: 2007 Page: 151-164
Author(s): Christian Domingo, Adalberto Pacheco, Miguel Hinojosa, Montserrat Bosque
New Therapeutic Interventions in Airway Inflammatory and Allergic Diseases
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5 Issue: 4 Year: 2006 Page: 353-356
Author(s): M. Ennis
A Molecular Understanding of Mast Cell Activation and the Promise of Anti- Allergic Therapeutics
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2083-2091
Author(s): Martina Kovarova, Juan Rivera
Anti-IgE Significantly Changes Circulating Interleukin-25, Vitamin-D and Interleukin-33 Levels in Patients with Allergic Asthma
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 3 Year: 2019 Page: 3784-3795
Author(s): Arzu D. Yalcin,Rusen Uzun
IgE-Mediated Disorders: Current Therapeutics and New Strategies Involving Synthetic Peptides
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 7 Issue: 4 Year: 2008 Page: 252-263
Author(s): Antonio Verdoliva, Maria Rossi
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 8 Year: 2017 Page: 1216-1227
Author(s): Bin Li,Weihong Li,Xiaoli Li,Hong Zhou